Literature DB >> 8382790

Facile preparation of nuclease resistant 3' modified oligodeoxynucleotides.

H B Gamper1, M W Reed, T Cox, J S Virosco, A D Adams, A A Gall, J K Scholler, R B Meyer.   

Abstract

An efficient chemical procedure for the immobilization of carboxylate containing conjugate groups onto controlled pore glass (CPG) is described. The derivatized supports were used in the automated synthesis of an oligodeoxynucleotide (20-mer ODN) containing a 3' phosphodiester linked hexanol, aminohexyl, acridine, or cholesterol group. The stability of the oligomer in a hepatoma cell culture was found to be prolonged two to three fold by the presence of any of the 3' tails. By contrast, an aminohexyl group appended to the 5' terminus of the ODN only marginally improved its nuclease resistance. These data support the notion that antisense ODNs are primarily degraded by 3' exonucleases. Introduction of simple 3' tails which incorporate a normal phosphodiester linkage can increase ODN stability by interfering with these enzymes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382790      PMCID: PMC309076          DOI: 10.1093/nar/21.1.145

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

1.  alpha-DNA. VI: Comparative study of alpha- and beta-anomeric oligodeoxyribonucleotides in hybridization to mRNA and in cell free translation inhibition.

Authors:  C Gagnor; J R Bertrand; S Thenet; M Lemaître; F Morvan; B Rayner; C Malvy; B Lebleu; J L Imbach; C Paoletti
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

2.  Oligonucleotide interactions. 3. Circular dichroism studies of the conformation of deoxyoligonucleotides.

Authors:  C R Cantor; M M Warshaw; H Shapiro
Journal:  Biopolymers       Date:  1970       Impact factor: 2.505

3.  An improved CPG support for the synthesis of 3'-amine-tailed oligonucleotides.

Authors:  C R Petrie; M W Reed; A D Adams; R B Meyer
Journal:  Bioconjug Chem       Date:  1992 Jan-Feb       Impact factor: 4.774

4.  3'-modified antisense oligodeoxyribonucleotides complementary to calmodulin mRNA alter behavioral responses in Paramecium.

Authors:  R D Hinrichsen; D Fraga; M W Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

5.  Oligodeoxyribonucleotides containing 1,3-propanediol as nucleoside substitute.

Authors:  F Seela; K Kaiser
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

6.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

7.  Oligodeoxynucleotide stability in subcellular extracts and culture media.

Authors:  E Wickstrom
Journal:  J Biochem Biophys Methods       Date:  1986-09

8.  Comparative hybrid arrest by tandem antisense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylphosphonates in a cell-free system.

Authors:  L J Maher; B J Dolnick
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

9.  Physicochemical properties of phosphorothioate oligodeoxynucleotides.

Authors:  C A Stein; C Subasinghe; K Shinozuka; J S Cohen
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

10.  In vivo stability and kinetics of absorption and disposition of 3' phosphopropyl amine oligonucleotides.

Authors:  J G Zendegui; K M Vasquez; J H Tinsley; D J Kessler; M E Hogan
Journal:  Nucleic Acids Res       Date:  1992-01-25       Impact factor: 16.971

View more
  20 in total

1.  3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures.

Authors:  I V Kutyavin; I A Afonina; A Mills; V V Gorn; E A Lukhtanov; E S Belousov; M J Singer; D K Walburger; S G Lokhov; A A Gall; R Dempcy; M W Reed; R B Meyer; J Hedgpeth
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Factors influencing the extent and selectivity of alkylation within triplexes by reactive G/A motif oligonucleotides.

Authors:  J N Lampe; I V Kutyavin; R Rhinehart; M W Reed; R B Meyer; H B Gamper
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

3.  Characterization of aberrant melting peaks in unlabeled probe assays.

Authors:  Shale Dames; Rebecca L Margraf; David C Pattison; Carl T Wittwer; Karl V Voelkerding
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

4.  Selective glutaraldehyde-mediated coupling of proteins to the 3'-adenine terminus of polymerase chain reaction products.

Authors:  John G Bruno; Randy Crowell
Journal:  J Biomol Tech       Date:  2008-07

5.  Sequence-specific targeting and covalent modification of human genomic DNA.

Authors:  E S Belousov; I A Afonina; M A Podyminogin; H B Gamper; M W Reed; R M Wydro; R B Meyer
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

6.  Triplex targeting of a native gene in permeabilized intact cells: covalent modification of the gene for the chemokine receptor CCR5.

Authors:  E S Belousov; I A Afonina; I V Kutyavin; A A Gall; M W Reed; H B Gamper; R M Wydro; R B Meyer
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

7.  Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.

Authors:  D Scott Wilbur; Steven I Park; Ming-Kuan Chyan; Feng Wan; Donald K Hamlin; Jaideep Shenoi; Yukang Lin; Shani M Wilbur; Franz Buchegger; Anastasia Pantelias; John M Pagel; Oliver W Press
Journal:  Bioconjug Chem       Date:  2010-07-21       Impact factor: 4.774

8.  Reagents for astatination of biomolecules. 3. Comparison of closo-decaborate(2-) and closo-dodecaborate(2-) moieties as reactive groups for labeling with astatine-211.

Authors:  D Scott Wilbur; Ming-Kuan Chyan; Donald K Hamlin; Matthew A Perry
Journal:  Bioconjug Chem       Date:  2009-03-18       Impact factor: 4.774

Review 9.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

10.  Antisense oligodeoxynucleotides: synthesis, biophysical and biological evaluation of oligodeoxynucleotides containing modified pyrimidines.

Authors:  Y S Sanghvi; G D Hoke; S M Freier; M C Zounes; C Gonzalez; L Cummins; H Sasmor; P D Cook
Journal:  Nucleic Acids Res       Date:  1993-07-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.